Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Searching for Novel Candidate Small Molecules for Ameliorating Idiopathic Pulmonary Fibrosis: a Narrative Review. | Biomol Ther (Seoul) | 2023 | 37254717 | PubTator, text mining | PubMed |
| Breast cancer prevention with liquiritigenin from licorice through the inhibition of aromatase and protein biosynthesis in high-risk women's breast tissue. | Sci Rep | 2023 | 37253812 | PubTator, text mining | PubMed |
| Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. | Nat Commun | 2023 | 37253718 | PubTator, text mining | PubMed |
| GATA6 regulates anti-angiogenic properties in human cardiac fibroblasts via modulating LYPD1 expression. | Regen Ther | 2023 | 37251737 | PubTator, text mining | PubMed |
| Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. | Nutrients | 2023 | 37242293 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Fibroepithelial Lesions of the Breast. | Int J Mol Sci | 2023 | 37240386 | PubTator, text mining | PubMed |
| Extracellular Targets to Reduce Excessive Scarring in Response to Tissue Injury. | Biomolecules | 2023 | 37238628 | PubTator, text mining | PubMed |
| LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung. | Sci Adv | 2023 | 37235663 | PubTator, text mining | PubMed |
| Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. | Dis Markers | 2023 | 37215201 | PubTator, text mining | PubMed |
| The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer. | Front Cell Dev Biol | 2023 | 37215076 | PubTator, text mining | PubMed |
| Meta-analysis of expression and the targeting of cell adhesion associated genes in nine cancer types - A one research lab re-evaluation. | Comput Struct Biotechnol J | 2023 | 37206618 | PubTator, text mining | PubMed |
| Recent Advances in Nanopore Technology for Copper Detection and Their Potential Applications. | Nanomaterials (Basel) | 2023 | 37177118 | PubTator, text mining | PubMed |
| Reciprocal Regulation of Cancer-Associated Fibroblasts and Tumor Microenvironment in Gastrointestinal Cancer: Implications for Cancer Dormancy. | Cancers (Basel) | 2023 | 37173977 | PubTator, text mining | PubMed |
| Pancreatic cancer stemness: dynamic status in malignant progression. | J Exp Clin Cancer Res | 2023 | 37173787 | PubTator, text mining | PubMed |
| Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. | Nat Commun | 2023 | 37156840 | PubTator, text mining | PubMed |
| The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness. | Proc Natl Acad Sci U S A | 2023 | 37155842 | PubTator, text mining | PubMed |
| Initiation of fibronectin fibrillogenesis is an enzyme-dependent process. | Cell Rep | 2023 | 37148241 | PubTator, text mining | PubMed |
| New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells. | Biomed Pharmacother | 2023 | 37146419 | PubTator, text mining | PubMed |
| Transcriptomic analysis of glutamate-induced HT22 neurotoxicity as a model for screening anti-Alzheimer's drugs. | Sci Rep | 2023 | 37142620 | PubTator, text mining | PubMed |
| Copper-binding proteins genes set predicting the overall survival and immune infiltration in hepatocellular carcinoma by bioinformatic analysis. | Biochem Biophys Rep | 2023 | 37125079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=20